Copyright
©The Author(s) 2019.
World J Clin Oncol. Apr 24, 2019; 10(4): 166-182
Published online Apr 24, 2019. doi: 10.5306/wjco.v10.i4.166
Published online Apr 24, 2019. doi: 10.5306/wjco.v10.i4.166
Figure 1 Flow chart of the number and selection of patients/controls in the study population.
- Citation: Maurya N, Singh R, Goel A, Singhai A, Singh UP, Agrawal V, Garg M. Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3β/ β-catenin in urinary bladder cancer patients. World J Clin Oncol 2019; 10(4): 166-182
- URL: https://www.wjgnet.com/2218-4333/full/v10/i4/166.htm
- DOI: https://dx.doi.org/10.5306/wjco.v10.i4.166